Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy
- 25 September 2012
- journal article
- Published by Elsevier BV in Clinical Genitourinary Cancer
- Vol. 11 (1), 27-32
- https://doi.org/10.1016/j.clgc.2012.08.003
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The Current Role of Androgen Deprivation in Patients Undergoing Dose-Escalated External Beam Radiation Therapy for Clinically Localized Prostate CancerProstate Cancer, 2012
- ESUR prostate MR guidelines 2012European Radiology, 2012
- Randomized study evaluating testosterone recovery using short-versuslong-acting luteinizing hormone releasing hormone agonistsCanadian Urological Association Journal, 2011
- Oligometastases revisitedNature Reviews Clinical Oncology, 2011
- The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate CancerEuropean Urology, 2011
- Prostate Cancer: PET with 18F-FDG, 18F- or 11C-Acetate, and 18F- or 11C-CholineJournal of Nuclear Medicine, 2010
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised DiseaseEuropean Urology, 2010
- Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancerRadiotherapy and Oncology, 2009
- Using PSA to Guide Timing of Androgen Deprivation in Patients with T0–4 N0–2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891)European Urology, 2007
- The Natural History of Noncastrate Metastatic Prostate Cancer after Radical ProstatectomyEuropean Urology, 2006